ROYAL BANK OF CANADA - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0485
+48400.0%
0.00%
Q4 2020$010.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders